Alterola Biotech Stock Market Value
| ABTI Stock | USD 0.01 0 32.76% |
| Symbol | Alterola |
Alterola Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alterola Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alterola Biotech.
| 12/24/2022 |
| 12/13/2024 |
If you would invest 0.00 in Alterola Biotech on December 24, 2022 and sell it all today you would earn a total of 0.00 from holding Alterola Biotech or generate 0.0% return on investment in Alterola Biotech over 720 days. Alterola Biotech is related to or competes with Crescita Therapeutics. Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecul... More
Alterola Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alterola Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alterola Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0927 | |||
| Maximum Drawdown | 171.75 | |||
| Value At Risk | (2.44) | |||
| Potential Upside | 32.76 |
Alterola Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alterola Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alterola Biotech's standard deviation. In reality, there are many statistical measures that can use Alterola Biotech historical prices to predict the future Alterola Biotech's volatility.| Risk Adjusted Performance | 0.0809 | |||
| Jensen Alpha | 1.98 | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | 3.38 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alterola Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alterola Biotech Backtested Returns
Alterola Biotech is out of control given 3 months investment horizon. Alterola Biotech secures Sharpe Ratio (or Efficiency) of 0.072, which signifies that the company had a 0.072% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-two different technical indicators, which can help you to evaluate if expected returns of 1.49% are justified by taking the suggested risk. Use Alterola Biotech Standard Deviation of 20.91, mean deviation of 8.23, and Risk Adjusted Performance of 0.0809 to evaluate company specific risk that cannot be diversified away. Alterola Biotech holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alterola Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Alterola Biotech is expected to be smaller as well. Use Alterola Biotech skewness, as well as the relationship between the day median price and relative strength index , to analyze future returns on Alterola Biotech.
Auto-correlation | -0.47 |
Modest reverse predictability
Alterola Biotech has modest reverse predictability. Overlapping area represents the amount of predictability between Alterola Biotech time series from 24th of December 2022 to 19th of December 2023 and 19th of December 2023 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alterola Biotech price movement. The serial correlation of -0.47 indicates that about 47.0% of current Alterola Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Alterola Biotech lagged returns against current returns
Autocorrelation, which is Alterola Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alterola Biotech's pink sheet expected returns. We can calculate the autocorrelation of Alterola Biotech returns to help us make a trade decision. For example, suppose you find that Alterola Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alterola Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alterola Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alterola Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alterola Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Alterola Biotech Lagged Returns
When evaluating Alterola Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alterola Biotech pink sheet have on its future price. Alterola Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alterola Biotech autocorrelation shows the relationship between Alterola Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Alterola Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Alterola Pink Sheet
Alterola Biotech financial ratios help investors to determine whether Alterola Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterola with respect to the benefits of owning Alterola Biotech security.